Related Experiment Video
Updated: Jan 19, 2026
03:56
Author Spotlight: Exploring the Impact of Lingnan Fire-Needle Therapy in Osteoporosis Intervention
Published on: April 26, 2024
1.2K
Lowering circulating apolipoprotein E levels improves aged bone fracture healing.
Rong Huang1,2, Xiaohua Zong1,2, Puviindran Nadesan2
1Duke Molecular Physiology Institute.
JCI Insight
|September 20, 2019
Summary
Elevated levels of apolipoprotein E (ApoE) hinder bone fracture healing and osteoblast differentiation in aging. Lowering ApoE levels in elderly mice significantly improved bone deposition and strength.
Area of Science:
- Gerontology
- Orthopedics
- Metabolic Research
Background:
- Age is a primary risk factor for delayed bone fracture healing.
- Circulating apolipoprotein E (ApoE) levels increase with age in humans and mice.
- The precise role of ApoE in age-related bone repair impairment is not fully understood.
Purpose of the Study:
- To identify the role of ApoE in age-associated bone fracture healing impairment.
- To investigate the underlying mechanisms by which ApoE affects osteoblast differentiation and bone repair.
- To explore ApoE as a potential therapeutic target for enhancing bone healing in the elderly.
Main Methods:
- Comparison of bone healing in wild-type (WT) and ApoE knockout (ApoE-/-) mice post-tibial fracture.
- In vitro studies using recombinant ApoE (rApoE) treatment on differentiating osteoblasts.
- Parabiosis models to assess the impact of circulating ApoE on bone repair.
- Adeno-associated virus (AAV)-siRNA system to reduce circulating ApoE levels in aged mice.
Main Results:
- ApoE-/- mice exhibited increased bone deposition in fracture calluses compared to WT mice.
- rApoE treatment inhibited osteoblast differentiation, matrix mineralization, and glycolytic activity, while promoting lipid uptake and fatty acid oxidation.
- Circulating ApoE was confirmed to strongly inhibit bone repair.
- Reducing ApoE levels in aged mice enhanced fracture callus bone deposition and mechanical strength.
Conclusions:
- Circulating ApoE acts as an aging factor that impairs bone fracture healing by altering osteoblast metabolism.
- ApoE significantly inhibits bone repair processes, particularly in older individuals.
- Targeting ApoE presents a novel therapeutic strategy for improving bone healing outcomes in the elderly.
Related Concept Videos
01:29Bone Disorders
5.1K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.1K
01:40Bone Remodeling
40.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.3K
01:31Osteoclasts in Bone Remodeling
3.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K
01:27Fractures: Bone Repair
5.1K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
5.1K
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
234
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
234
01:26Atherosclerosis III: Management
334
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
334